Original Research

Does oral creatine supplementation improve strength? A meta-analysis

Author and Disclosure Information

 

References

Data abstraction and statistical analysis

Two independent reviewers abstracted data, and a third reviewer resolved differences. For studies investigating multiple sprints, data from the first sprint only were included in statistical analysis because the first sprint is when peak power achievement is expected. A weighted mean difference (WMD) between creatine and placebo groups was calculated for each outcome using Review Manager 4.1 software (developed by The Cochrane Collaboration). A fixed effects model was used unless statistical heterogeneity was significant (P < .05), in which case a random effects model was used. Subanalyses were planned on several factors that were anticipated to be sources for variation, including (1) dose and duration of creatine administration, (2) concomitant resistance training, (3) different baseline level of physical training, (4) age, and (5) sex.

Results

Description of studies

After reviewing titles and available abstracts of more than 500 articles, we retrieved 66 potentially relevant studies, 16 of which met inclusion criteria for the analysis.17,20-34 Characteristics of these studies are summarized in the Table. Included studies represented 20 discrete samples and 414 subjects. Two studies20,21 evaluated creatine supplementation in men older than 60 years, whereas all the others studied younger subjects (range, 18–36 years). Only 1 study included women.17 Creatine dosages were similar across included studies (typically 20 g/d for the first 4–7 days of supplementation and 5 g/d thereafter). Studies that evaluated maximal weight lifting performance were more likely to include adjuvant resistance training programs in their protocols than those that evaluated cycle ergometry sprint or isokinetic dynamometer performance. None included cycle ergometry training.

TABLE

Characteristics of included studies

ReferenceNo. subjects (sex)Dose per day and durationTraining levelWeight training during study?Outcome measurementQuality score (out of 10)Comparability of creatine & placebo groups at baseline*
Barnett 199617 (M)280 mg/kg ×4 dActiveNoCP2.5+
Cooke 199512 (M)20 g ×5 dUntrainedNoCP2.5+
Cooke 199780 (M)20 g ×5 dTrained or activeNoCP2+++
Dawson 199518 (M), 22(M)20 g ×5 dActiveNoCP3+++
Jones 199916 (M)20 g ×5 d then 5 g ×10 wkTrainedYesCM3+++
Stone 199920 (M)0.22 g/kg ×35 dTrainedYesCM, BP, S4.5+++
Kelly 199818 (M)20 g ×5 d then 5 g ×26 dTrainedYes3BP2
Noonan 199839 (M)20 g ×5 d then 300 mg/kg ×8 wkTrainedYesBP5.5+++
Peeters 199935 (M)20 g ×3 d then 10 g ×6 wkTrainedYesBP3+++
Vandenberghe 199719 (F)20 g ×4 d then 5 g ×10 wkUntrainedYesBP, S5+++
Pearson 199916 (M)5 g ×10 wkTrainedYesBP, S, PT3+++
Volek 199919 (M)25 g ×7 d then 5 g ×12 wkTrainedYesBP, S4.5+++
Gilliam 200023 (M)20 g ×5 dActive but untrainedNoPT2.5+
Rawson 1999§20 (M)20 g ×10 d then 4 g ×20 dUntrainedNoAF, PT4.5+++
Rawson 2000§17 (M)20 g ×5 dUntrainedNoAF3.5+++
Becque 200023 (M)20 g ×5 d then 2 g ×6 wkTrainedYesAF5+
*Comparability between groups was assessed for age, anthropomorphic measurements, and strength outcomes. +++ = similar for all 3 characteristics; + = similar for strength outcome measurements; – = not comparable at baseline for strength outcome.
Four protocols with 20 subjects each evaluating the same strength outcome measurement reported in Cooke 1997.
Two separate experiments reported in Dawson 1995.
§Included subjects > 60 years old; in all others subjects were < 36 years old.
AF, 1 repetition maximum arm flexor strength; BP, 1 repetition maximum bench press strength; 3BP, 3 repetition maximum bench press strength; CM, cycle ergometer mean peak power; CP, cycle ergometer peak power; PT, isokinetic leg flexion/extension peak torque; S, 1 repetition maximum squat strength.

Methodological quality of included studies

The methodological quality of studies was generally low (Table). The mean quality score was 3.5 ± 1.2 (mean ± SD) out of a possible 10 (range, 2–5.5). None of the studies identified the method of randomization used or specifically reported an intention-to-treat analysis. None specifically reported masking of outcome assessment. In general, these significant flaws in study design would tend to result in overestimation of the benefit of creatine supplementation.

Absolute strength

When 1- to 3-repetition maximum bench press strength measurements were statistically combined (they were homogeneous), the creatine supplementation group showed an absolute strength increase of 6.85 kg (95% confidence interval [CI], 5.24–8.47; n = 143) lifted per repetition greater than that seen with placebo alone (Figure 1). There was no additional advantage in strength performance after 9 to 12 weeks of supplementation (WMD = 6.6 kg; 95% CI, 3.5–9.5) compared with 4 to 8 weeks of supplementation (WMD = 6.6 kg; 95% CI, 4.8–8.4). Subanalysis for an interaction with resistance training, previous training level, age, or sex was not possible because all studies measuring bench press strength except one17 investigated creatine supple mentation in previously trained young men who continued resistance training during supplementation. The 1 study in previously sedentary young women17 did find a trend toward increased bench press strength, although independently this change was not statistically significant.

Pages

Recommended Reading

Relationships between physician practice style, patient satisfaction, and attributes of primary care
MDedge Family Medicine
Do written action plans improve patient outcomes in asthma? An evidence-based analysis
MDedge Family Medicine
Management of the low-grade abnormal Pap smear: What are women’s preferences?
MDedge Family Medicine
Antioxidants do not prevent heart disease in high-risk individuals
MDedge Family Medicine
β-Blocker survival benefit outweighs side-effect risks
MDedge Family Medicine
B-type natriuretic peptide is an accurate predictor of heart failure in the emergency department
MDedge Family Medicine
Hair apposition technique is better than suturing scalp lacerations
MDedge Family Medicine
Do the risks of estrogen plus progestin outweigh the benefits in healthy post-menopausal women?
MDedge Family Medicine
Electronic solutions to implementing lipid guidelines
MDedge Family Medicine
Cancer risk assessment from family history: Gaps in primary care practice
MDedge Family Medicine